Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Filings indexed 2,009 across all filing types
Latest filing 2021-03-09 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
关于收到《中国证监会行政许可申请终止审查通知书》的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from the company regarding the receipt of a notice from the China Securities Regulatory Commission (CSRC) about the termination of the review of the company's non-public issuance of A shares. It mentions the company's board meeting decisions and the regulatory body's administrative procedure. The document is short (630 characters) and serves as a formal announcement of a regulatory decision rather than a detailed financial report or filing. It does not contain financial statements, audit information, or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-03-09 Chinese
第九届监事会第五次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolution passed at the fifth meeting of the ninth Supervisory Board of the company. It details the meeting attendance, the agenda item about terminating a non-public issuance of A shares, and the voting results. It references compliance with laws and company articles but does not contain financial statements or detailed financial data. The document is an official announcement of a board meeting decision rather than a full report or financial disclosure. It is not a report publication announcement since it contains substantive meeting resolution content. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2021-02-26 Chinese
独立董事关于第九届董事会第六次会议相关事项的事前认可意见和独立意见
Board/Management Information Classification · 95% confidence The document is a statement from independent directors regarding the termination of a non-public issuance of A shares and the withdrawal of the related application to the China Securities Regulatory Commission. It contains independent opinions and pre-approval opinions about a specific board decision. The document is short (810 characters) and focuses on board-related opinions rather than financial data or report publication. It does not contain financial statements or detailed financial analysis. This fits best under Board/Management Information (MANG), as it relates to board decisions and opinions on corporate actions.
2021-02-26 Chinese
第九届董事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution passed at the company's ninth board of directors' sixth meeting. It details the meeting's convening, attendance, and the approval of a proposal to terminate a non-public issuance of A shares and withdraw the application. The document includes voting results and references to related announcements and independent directors' opinions. It does not contain financial statements or detailed financial data but is a corporate governance announcement about board decisions. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report or financial statement itself, but a board meeting resolution announcement.
2021-02-26 Chinese
关于终止本次非公开发行A股股票事项及撤回申请文件的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the termination of a previously planned non-public issuance of A shares and the withdrawal of the related application documents. It details the board and supervisory meetings, the process of regulatory feedback from the China Securities Regulatory Commission, and the independent directors' opinions on the termination decision. The document does not contain financial statements or detailed financial data but rather communicates a corporate action related to capital raising activities. This fits the category of a Capital/Financing Update (CAP), as it updates on the company's financing activities and capital structure changes by announcing the termination of a share issuance and withdrawal of the application.
2021-02-26 Chinese
关于全资子公司获得高新技术企业证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (616 characters) regarding the company's wholly owned subsidiary receiving a High-Tech Enterprise Certificate, which grants tax benefits. It is an official disclosure about a regulatory or operational update, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial data. It is not a report publication announcement since it does not mention any report being published or attached. The content fits best under Regulatory Filings (RNS) as a general regulatory announcement about a certificate and tax status.
2021-02-22 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.